Our goal in to provide access for lower and middle income people in LDCs to groundbreaking new drugs.

We provide technical assistance for manufacturers to produce pharmaceuticals of comparable: efficacy, safety and quality to the originator drugs.


Small molecule API development and validation.

Cost effective methods for API production as well as the sourcing and supply of API.


Darvel Generics was founded in 2016 with the concept of equal access for all patients to quality medicines.